Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PLATELET GLYCOPROTEIN IIB/IIIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kiefel, V
      Platelet antibodies and diagnosis of immune-mediated thrombocytopenia

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    2. Vaisman, D; Ferguson, JJ
      Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Axelrod, DA; Wakefield, TW
      Future directions in antithrombotic therapy: Emphasis on venous thromboembolism

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    4. Bogousslavsky, J; Leclerc, JR
      Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke

      CEREBROVASCULAR DISEASES
    5. Neumann, FJ; Hochholzer, W; Pogatsa-Murray, G; Schomig, A; Gawaz, M
      Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    6. Coller, BS
      Anti-GPIIb/IIIa drugs: Current strategies and future directions

      THROMBOSIS AND HAEMOSTASIS
    7. Israels, SJ; McMillan-Ward, EM; Easton, J; Robertson, C; McNicol, A
      CD63 associates with the alpha(IIb)beta(3) integrin-CD9 complex on the surface of activated platelets

      THROMBOSIS AND HAEMOSTASIS
    8. Mathis, AS; Meswani, P; Spinler, SA
      Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines

      PHARMACOTHERAPY
    9. Akkerhuis, KM; Deckers, JW; Lincoff, AM; Tcheng, JE; Boersma, E; Anderson, K; Balog, C; Califf, RM; Topol, EJ; Simoons, ML
      Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    10. Park, JW; Smolen, J
      Monoclonal antibody therapy

      ADVANCES IN PROTEIN CHEMISTRY, VOL 56
    11. Tardiff, BE; Jennings, LK; Harrington, RA; Gretler, D; Potthoff, RF; Vorchheimer, DA; Eisenberg, PR; Lincoff, AM; Labinaz, M; Joseph, DM; McDougal, MF; Kleiman, NS
      Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes - Prospective analysis from PURSUIT

      CIRCULATION
    12. Gilchrist, IC; O'Shea, JC; Kosoglou, T; Jennings, LK; Lorenz, TJ; Kitt, MM; Kleiman, NS; Talley, D; Aguirre, F; Davidson, C; Runyon, J; Tcheng, JE
      Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention

      CIRCULATION
    13. Debili, N; Robin, C; Schiavon, V; Letestu, R; Pflumio, F; Mitjavila-Garcia, MT; Coulombel, L; Vainchenker, W
      Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates

      BLOOD
    14. Tillmanns, H
      Noninvasive acute therapy of myocardial infarction

      ANAESTHESIST
    15. Vahdat, B; Canavy, I; Fourcade, L; Garcia, E; Quilici, J; Bonnet, JL; Bory, M
      Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    16. Liu, FQ; Craft, RM; Morris, SA; Carroll, RC
      Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    17. Mousa, SA; Khurana, S; Forsythe, MS
      Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography - Differentiation among glycoprotein IIb/IIIa antagonists

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    18. Kereiakes, DJ; Fry, E; Matthai, W; Niederman, A; Barr, L; Brodie, B; Zidar, J; Casale, P; Christy, G; Moliterno, D; Lengerich, R; Broderick, T; Shimshak, T; Cohen, M
      Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first"

      JOURNAL OF INVASIVE CARDIOLOGY
    19. Mousa, SA; Forsythe, M; Bozarth, J; Jin, FQ; Confalone, PN
      Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin

      CORONARY ARTERY DISEASE
    20. Llevadot, J; Coulter, SA; Giugliano, RP
      A practical approach to the diagnosis and management of thrombocytopenia associated with glycoprotein IIb/IIIa receptor inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    21. Mukherjee, D; Moliterno, DJ
      Monitoring antiplatelet therapy - What is the best method?

      CLINICAL PHARMACOKINETICS
    22. Akkerhuis, KM; Deckers, JW; Boersma, E; Harrington, RA; Stepinska, J; Mahaffey, KW; Wilcox, RG; Lincoff, AM; Keltai, M; Topol, EJ; Califf, RM; Simoons, ML
      Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT

      EUROPEAN HEART JOURNAL
    23. Fintel, DJ; Ledley, GS
      Management of patients with non-ST-segment elevation acute coronary syndromes: Insights from the PURSUIT trial

      CLINICAL CARDIOLOGY
    24. Qureshi, AI; Suri, MFK; Khan, J; Fessler, RD; Guterman, LR; Hopkins, LN
      Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: Preliminary experience

      NEUROSURGERY
    25. Qureshi, AI; Luft, AR; Sharma, M; Guterman, LR; Hopkins, LN
      Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I - Pathophysiological and pharmacological features

      NEUROSURGERY
    26. Tcheng, JE; O'Shea, JC; Cohen, EA; Pacchiana, CM; Kitt, MM; Lorenz, TJ; Greenberg, S; Strony, J; Califf, RM; Buller, C; Cantor, WJ; Joseph, DM; Kitt, MM; Lincoff, AM; Madan, M; Popma, J; Teirstein, P; Cohen, E; Balleza, L; Parsons, P; Lui, H; Young, J; Fox, R; Labinaz, M; Jelley, J; Williams, J; Cohen, D; Trovato, M; Smith, J; Henry, P; Chisholm, R; O'Donnell, D; Talley, JD; Pacheco, R; Timmis, S; Muraka, A; Mann, T; Cubeddu, G; Tannenbaum, M; Greene, J; Santoian, E; Wash, M; Sheldon, S; Pronesti, L; Jain, A; Alonzo, M; Seidelin, P; Richards, J; Lopez, M; Dittenber, R; Johnson, K; Levine, G; Maresh, K; Ferrando, T; Sarembock, I; Snyder, L; Kieval, J; Herlan, L; Miller, M; Bembridge, D; Nair, R; Hickel, L; Kiernan, F; Murphy, D; Cloutier, J; Conn, E; Beardsley, J; Ritchie, M; Cragen, D; Jafar, MZ; Counihan, P; Rosenfelder, D; Ducas, J; Montebruno, L; Carere, R; Radons, B; Williams, L; Owens, W; Dougal, R; Feldman, R; Audrain, D; Karamali, A; Smith, M; Blankenship, J; Demko, SL; Thompson, M; Gacoich, G; Chiodo, V; Noll, P; Ledley, G; Miller, C; Felten, W; Garner, B; Chandler, AB; Easler, P; Albin, G; Page, A; Maddox, W; Allen, S; Gilchrist, I; Moore, R; Zimmerman, H; Curtis, M; Hildebrand, K; Greene, R; Healy, E; Meengs, W; Carson, D; George, J; Roncevich, T; Aharonian, V; Browning, R; Kostuk, W; Carr, S; Feit, F; Gostomsky, B; Butman, S; Hannah, E; Hassel, CD; Hartley, D; Shook, T; Hiller-Mullin, S; Brill, D; Dillion, M; Armstrong, B; Kerns, D; Pichard, A; Okubagzi, P; Nasser, T; Driver, L; Garrett, J; Boltey, L; Stouffer, G; Potter, M; Amidon, T; Eggert, S; Taussig, A; Potter, K; Natarajan, M; Tartaglia, C; Werner, J; Dunlap, T; Harrold-Runge, P; Davidson, C; Goodreau, L; Herzog, W; Calamunci, N; Slater, A; Tormey, D; Phillips, W; White, D; Sridhar, K; White, J; Goodman, D; Buchbinder, M; Nasser, V; Rapeport, K; Vorman, P; Weiner, B; Borbone, M; Shadoff, N; Paap, C; Rehman, A; Haag, E; Burchenal, J; Kioussopoulos, K; Senior, D; Senior, J; Piana, R; Kirshenbaum, J; Chan, S; Chowdry, A; Kraft, P; Clark, V; Fox, M; Deutsch, E; Shannon, T; Quesada, R; Brotherton, J; Murrin, C; Cinderella, J; Hearne, S; Seefried, V; Farah, T; Pakstis, D; Bartolet, B; Bond, C; Debarardinis, C; Montory, D; Smith, G; Gray, D; Phillips, P; Hathaway, S; Manoukian, S; Patrick, C; Yakubov, S; Brooks, J; Block, P; Block, B; Muhlestein, JB; Kim, S; Shalev, Y; Schmidt, W; Resar, J; Citro, K; Stine, R; Zumbuhl, J; Moreyra, A; Kreiger, S; Berger, P; Cannon, CP; Fisher, L; Hasselblad, V; Foster, A; Joseph, D; Madan, M; McLendon, C; Rund, M; Tillery, N; Wood, F; Mahaffey, KW; Irwin, C; Kulick, D; Johnson, N; Chen, J; Greenberg, S; Hogeboom, C; Lorenz, TJ; Terifay, R; Strony, J; Veltri, E
      Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

      LANCET
    27. Abumiya, T; Fitridge, R; Mazur, C; Copeland, BR; Koziol, JA; Tschopp, JF; Pierschbacher, MD; del Zoppo, GJ
      Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia

      STROKE
    28. Gratsiansky, NA
      Unstable angina - Acute coronary syndrome without ST-segment elevations. Antithrombotic treatment

      KARDIOLOGIYA
    29. Akkerhuis, KM; Maas, ACP; Klootwijk, PAJ; Krucoff, MW; Meij, S; Califf, RM; Simoons, ML
      Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction

      JOURNAL OF ELECTROCARDIOLOGY
    30. Verstraete, M
      Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development

      CIRCULATION
    31. Baron, JH; Moiseeva, EP; de Bono, DP; Abrams, KR; Gershlick, AH
      Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis

      CARDIOVASCULAR RESEARCH
    32. Baron, JH; Gershlick, AH; Hogrefe, K; Armstrong, J; Holt, CM; Aggarwal, RK; Azrin, M; Ezekowitz, M; de Bono, DP
      In vitro evaluation of c7E3-Fab (ReoPro (TM)) eluting polymer-coated coronary stents

      CARDIOVASCULAR RESEARCH
    33. Steinhubl, SR
      Antiplatelet agents in cardiology: The choice of therapy

      ANNALS OF THORACIC SURGERY
    34. Bates, ER
      Ischemic complications after percutaneous transluminal coronary angioplasty

      AMERICAN JOURNAL OF MEDICINE
    35. Guzzo, JA; Nichols, TC
      Possible anaphylactic reaction to abciximab

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    36. Jordan, R; Mascelli, MA
      Pharmacological differentiation of GP IIb/IIIa inhibitors

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    37. Curley, GP; Blum, H; Humphries, MJ
      Integrin antagonists

      CELLULAR AND MOLECULAR LIFE SCIENCES
    38. Vanscoy, GJ; Rihn, TL
      GP Ilb IIIa receptor inhibitors: Clinical and cost considerations in acutecoronary syndromes

      FORMULARY
    39. Stringer, KA
      The evolving role of platelet glycoprotein IIb IIIa inhibitors in the management of acute coronary syndromes

      ANNALS OF PHARMACOTHERAPY
    40. Greilich, PE; Alving, BM; Longnecker, D; Carr, ME; Whitten, CW; Chang, AS; Reid, TJ
      Near-site monitoring of the antiplatelet drug abciximab using the Hemodyneanalyzer and modified Thrombelastograph

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    41. Holper, EM; Giugliano, RP; Antman, EM
      Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction

      CORONARY ARTERY DISEASE
    42. Barrett, JS; Yu, J; Kapil, R; Padovani, P; Brown, F; Ebling, WF; Corjay, MH; Reilly, TM; Bozarth, JM; Mousa, SA; Pieniaszek, HJ
      Disposition and exposure of the fibrinogen receptor antagonist XV459 on alpha(IIB)beta(3), binding sites in the guinea pig

      BIOPHARMACEUTICS & DRUG DISPOSITION
    43. Narayanan, S; Hamasaki, N
      Current concepts of coagulation and fibrinolysis

      ADVANCES IN CLINICAL CHEMISTRY, VOL 33
    44. Schror, K
      Antiintregrins - new antiplatelet agents for prevention and treatment of acute coronary syndrome

      WIENER KLINISCHE WOCHENSCHRIFT
    45. Dyke, C; Bhatia, D
      Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization - Management strategies for the cardiac surgeon

      JOURNAL OF CARDIOVASCULAR SURGERY
    46. Price, DT; Loscalzo, J
      Cellular adhesion molecules and atherogenesis

      AMERICAN JOURNAL OF MEDICINE
    47. Scarborough, RM
      Development of eptifibatide

      AMERICAN HEART JOURNAL
    48. DEITCH JS; WILLIAMS JK; ADAMS MR; FLY CA; HERRINGTON DM; JORDAN RE; NAKADA MT; JAKUBOWSKI JA; GEARY RL
      EFFECTS OF BETA-3-INTEGRIN BLOCKADE (C7E3) ON THE RESPONSE TO ANGIOPLASTY AND INTRAARTERIAL STENTING IN ATHEROSCLEROTIC NONHUMAN-PRIMATES

      Arteriosclerosis, thrombosis, and vascular biology
    49. ZED PJ; FRIGHETTO L; SUNDERJI R; MARRA CA
      COST-EFFECTIVENESS ANALYSIS OF ABCIXIMAB - A CANADIAN HOSPITAL PERSPECTIVE

      The Annals of pharmacotherapy
    50. CAVENAGH JD; CAHILL MR; KELSEY SM
      ADHESION MOLECULES IN CLINICAL MEDICINE

      Critical reviews in clinical laboratory sciences
    51. MEYER BJ
      ANTITHROMBOTIC DRUGS - INSIGHTS FROM CARDIOLOGY

      Cerebrovascular diseases
    52. Kleiman, NS
      Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists

      CORONARY ARTERY DISEASE
    53. DeSilvey, DL
      Management of acute ischemic coronary syndromes: The present and future

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    54. BERKOWITZ SD; SANE DC; SIGMON KN; SHAVENDER JH; HARRINGTON RA; TCHENG JE; TOPOL EJ; CALIFF RM
      OCCURRENCE AND CLINICAL-SIGNIFICANCE OF THROMBOCYTOPENIA IN A POPULATION UNDERGOING HIGH-RISK PERCUTANEOUS CORONARY REVASCULARIZATION

      Journal of the American College of Cardiology
    55. LEHNE G; NORDAL KP; MIDTVEDT K; GOGGIN T; BROSSTAD F
      INCREASED POTENCY AND DECREASED ELIMINATION OF LAMIFIBAN, A GPIIB-IIIA ANTAGONIST, IN PATIENTS WITH SEVERE RENAL DYSFUNCTION

      Thrombosis and haemostasis
    56. WITTIG K; ROTHE G; SCHMITZ G
      INHIBITION OF FIBRINOGEN BINDING AND SURFACE RECRUITMENT OF GPIIB IIIA AS DOSE-DEPENDENT EFFECTS OF THE RGD-MIMETIC MK-852/

      Thrombosis and haemostasis
    57. REFINO CJ; MODI NB; BULLENS S; PATER C; LIPARI MT; ROBARGE K; BLACKBURN B; BERESINI M; WELLER T; STEINER B; BUNTING S
      PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF A POTENT, NONPEPTIDIC, GP IIB IIIA RECEPTOR ANTAGONIST FOLLOWING MULTIPLE ORAL ADMINISTRATIONS OF A PRODRUG FORM/

      Thrombosis and haemostasis
    58. WURDEMAN RL; HILLEMAN DE; MOOSS AN
      RESTENOSIS, THE ACHILLES-HEEL OF CORONARY ANGIOPLASTY

      Pharmacotherapy
    59. DOBESH PP; LATHAM KA
      ADVANCING THE BATTLE AGAINST ACUTE ISCHEMIC SYNDROMES - A FOCUS ON THE GP IIB-IIIA INHIBITORS

      Pharmacotherapy
    60. REBELLO SS; HUANG JB; SHIN WJ; SAITO K; KANEKO M; SAITOH Y; LUCCHESI BR
      PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/

      Journal of cardiovascular pharmacology
    61. BERKOMPAS DC
      ABCIXIMAB COMBINED WITH ANGIOPLASTY IN A PATIENT WITH RENAL-ARTERY STENT SUBACUTE THROMBOSIS

      Catheterization and cardiovascular diagnosis
    62. FOSTER RH; WISEMAN LR
      ABCIXIMAB - AN UPDATED REVIEW OF ITS USE IN ISCHEMIC-HEART-DISEASE

      Drugs
    63. GAMMIE JS; ZENATI M; KORMOS RL; HATTLER BG; WEI LM; PELLEGRINI RV; GRIFFITH BP; DYKE CM
      ABCIXIMAB AND EXCESSIVE BLEEDING IN PATIENTS UNDERGOING EMERGENCY CARDIAC OPERATIONS

      The Annals of thoracic surgery
    64. GUETTA V; LINCOFF AM
      CLINICAL-EXPERIENCE WITH ABCIXIMAB DURING CORONARY REVASCULARIZATION - AN OVERVIEW

      Biodrugs
    65. FERGUSON JJ; LAU TK
      NEW ANTIPLATELET AGENTS FOR ACUTE CORONARY SYNDROMES

      The American heart journal
    66. MOUSA SA; CHERESH DA
      RECENT ADVANCES IN CELL-ADHESION MOLECULES AND EXTRACELLULAR-MATRIX PROTEINS - POTENTIAL CLINICAL IMPLICATIONS

      Drug discovery today
    67. HAUBNER R; FINSINGER D; KESSLER H
      STEREOISOMERIC PEPTIDE LIBRARIES AND PEPTIDOMIMETICS FOR DESIGNING SELECTIVE INHIBITORS OF THE ALPHA(V)BETA(3) INTEGRIN FOR A NEW CANCER-THERAPY

      Angewandte Chemie, International Edition in English
    68. VOSS R; TILLMANNS H
      NEW ASPECTS OF ANTITHROMBOTIC TREATMENT I N UNSTABLE ANGINA-PECTORIS

      Zeitschrift fur Kardiologie
    69. JOSEPH JE; MACHIN SJ
      NEW ANTIPLATELET DRUGS

      Blood reviews
    70. SITGES M; VILLA FP
      MASSIVE PULMONARY HEMORRHAGE IN A PATIENT TREATED WITH A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR/

      International journal of cardiology
    71. SUZUKI K; SAKAI Y; HISAMICHI N; TANIUCHI Y; SATO K; TERAZAKI C; KAKU S; KAWASAKI T; YANO S; INAGAKI O; MASUHO Y
      COMPARISON OF THE ANTIPLATELET EFFECT OF YM337 AND ABCIXIMAB IN RHESUS-MONKEYS

      European journal of pharmacology
    72. MAKKAR RR; LITVACK F; EIGLER NL; NAKAMURA M; IVEY PA; FORRESTER JS; SHAH PK; JORDAN RE; KAUL S
      EFFECTS OF GP IIB IIIA RECEPTOR MONOCLONAL-ANTIBODY (7E3), HEPARIN, AND ASPIRIN IN AN EX-VIVO CANINE ARTERIOVENOUS SHUNT MODEL OF STENT THROMBOSIS/

      Circulation
    73. GREILICH PE; ALVING BM; ONEILL KL; CHANG AS; REID TJ
      A MODIFIED THROMBOELASTOGRAPHIC METHOD FOR MONITORING C7E3 FAB IN HEPARINIZED PATIENTS

      Anesthesia and analgesia
    74. WHITE HD
      UNMET THERAPEUTIC NEEDS IN THE MANAGEMENT OF ACUTE-ISCHEMIA

      The American journal of cardiology
    75. PHILLIPS DR; SCARBOROUGH RM
      CLINICAL-PHARMACOLOGY OF EPTIFIBATIDE

      The American journal of cardiology
    76. BERGELSON BA; FISHMAN RF; TOMMASO CL
      ABRUPT VESSEL CLOSURE - CHANGING IMPORTANCE, MANAGEMENT, AND CONSEQUENCES

      The American heart journal
    77. GENETTA TB; MAURO VF
      ABCIXIMAB - A NEW ANTIAGGREGANT USED IN ANGIOPLASTY

      The Annals of pharmacotherapy
    78. SILBER S; DORR R
      STRATEGIES OF ANTITHROMBOTIC THERAPY IN P ATIENTS WITH LOW-RISK AND HIGH-RISK PTCA

      Herz
    79. MURRAY LJ; MANDICH D; BRUNO E; DIGIUSTO RK; FU WC; SUTHERLAND DR; HOFFMAN R; TSUKAMOTO A
      FETAL BONE-MARROW CD34(-CELLS()CD41(+) CELLS ARE ENRICHED FOR MULTIPOTENT HEMATOPOIETIC PROGENITORS, BUT NOT FOR PLURIPOTENT STEM)

      Experimental hematology
    80. COLLER BS; ANDERSON KM; WEISMAN HF
      THE ANTI-GPIIB-IIIA AGENTS - FUNDAMENTAL AND CLINICAL ASPECTS

      Haemostasis
    81. MODI NB; REYNOLDS T; BAUGHMAN SA; THOMAS DA; PAASCH BD; SMITH SY
      PHARMACOKINETICS AND PHARMACODYNAMICS OF TP-9201, A GPIIBIIIA ANTAGONIST, ADMINISTERED IN COMBINATION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, HEPARIN, AND ASPIRIN IN BEAGLES

      Journal of cardiovascular pharmacology
    82. LEISTIKOW EA
      PLATELET INTERNALIZATION IN EARLY THROMBOGENESIS

      Seminars in thrombosis and hemostasis
    83. MACHNIG T; POTRATZ J; SHEIKHZADEH A
      PREVENTION OF THROMBOTIC COMPLICATIONS IN INTERNATIONAL CARDIOLOGY - A REVIEW OF NEW PHARMACOLOGICAL APPROACHES

      Herz, Kreislauf
    84. WELLER T; ALIG L; BERESINI M; BLACKBURN B; BUNTING S; HADVARY P; MULLER MH; KNOPP D; LEVETTRAFIT B; LIPARI MT; MODI NB; MULLER M; REFINO CJ; SCHMITT M; SCHONHOLZER P; WEISS S; STEINER B
      ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS .2. AMIDOXIMES AS PRODRUGS OF AMIDINES

      Journal of medicinal chemistry
    85. JIN Y; DIETZ HC; MONTGOMERY RA; BELL WR; MCINTOSH I; COLLER B; BRAY PF
      GLANZMANN THROMBASTHENIA - COOPERATION BETWEEN SEQUENCE VARIANTS IN CIS DURING SPLICE-SITE SELECTION

      The Journal of clinical investigation
    86. VAHANIAN A; GARBARZ E
      MODERN ANTIPLATELET DRUGS IN UNSTABLE ANG INA

      Archives des maladies du coeur et des vaisseaux
    87. SCHAFER AI
      ANTIPLATELET THERAPY

      The American journal of medicine
    88. ESTRY DW; MATTSON JC; OESTERLE JR; MAHONEY GJ; PATTERSON WR; BELL TG
      BASSET HOUND HEREDITARY THROMBOPATHY - AN INHERITED DISORDER WITH DEFECTIVE PLATELET-AGGREGATION DESPITE NORMAL FIBRINOGEN BINDING AND RECEPTOR MOBILITY

      Comparative haematology international
    89. TAUB JW; WARRIER I; HOLTKAMP C; BEARDSLEY DS; LUSHER JM
      CHARACTERIZATION OF AUTOANTIBODIES AGAINST THE PLATELET GLYCOPROTEIN ANTIGENS IIB IIIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIA PURPURA/

      American journal of hematology
    90. SCHACHINGER V; ZEIHER AM
      NEW ASPECTS OF ANTITHROMBOTIC THERAPY DUR ING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)

      Zeitschrift fur Kardiologie
    91. KNIGHT DM; WAGNER C; JORDAN R; MCALEER MF; DERITA R; FASS DN; COLLER BS; WEISMAN HF; GHRAYEB J
      THE IMMUNOGENICITY OF THE 7E3 MURINE MONOCLONAL FAB ANTIBODY FRAGMENTVARIABLE REGION IS DRAMATICALLY REDUCED IN HUMANS BY SUBSTITUTION OF HUMAN FOR MURINE CONSTANT REGIONS

      Molecular immunology
    92. SUDO Y; KILGORE KS; LUCCHESI BR
      MONOCLONAL-ANTIBODY [7E3 F(AB')(2)] PREVENTS ARTERIAL BUT NOT VENOUS RETHROMBOSIS

      Journal of cardiovascular pharmacology
    93. MODI NB; BAUGHMAN SA; PAASCH BD; CELNIKER A; SMITH SY
      PHARMACOKINETICS AND PHARMACODYNAMICS OF TP-9201, A GPIIBIIIA ANTAGONIST, IN RATS AND DOGS

      Journal of cardiovascular pharmacology
    94. SCHROR K
      ANTIPLATELET DRUGS - A COMPARATIVE REVIEW

      Drugs
    95. POPMA JJ; COLLER BS; OHMAN EM; BITTL JA; WEITZ J; KUNTZ RE; LEON MB
      ANTITHROMBOTIC THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY

      Chest
    96. NICHOL JL; HORNKOHL AC; CHOI ES; HOKOM MM; PONTING I; SCHUENING FW; HUNT P
      ENRICHMENT AND CHARACTERIZATION OF PERIPHERAL BLOOD-DERIVED MEGAKARYOCYTE PROGENITORS THAT MATURE IN SHORT-TERM LIQUID CULTURE

      Stem cells
    97. JANG YS; LINCOFF AM; PLOW EF; TOPOL EJ
      CELL-ADHESION MOLECULES IN CORONARY-ARTERY DISEASE

      Journal of the American College of Cardiology
    98. ANDERSON HV; KIRKEEIDE RL; KRISHNASWAMI A; WEIGELT LA; REVANA M; WEISMAN HF; WILLERSON JT
      CYCLIC FLOW VARIATIONS AFTER CORONARY ANGIOPLASTY IN HUMANS - CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS AND ELIMINATION WITH 7E3 MONOCLONALANTIPLATELET ANTIBODY

      Journal of the American College of Cardiology
    99. MOHRI H; OHKUBO T
      BRIDGED PEPTIDE OF FIBRINOGEN BINDS TO PLATELETS ACTIVATED BY RGD PEPTIDE AS WELL AS BY ADP

      Peptides
    100. BAKER WF; BICK RL
      ANTIPHOSPHOLIPID ANTIBODIES IN CORONARY-ARTERY DISEASE - A REVIEW

      Seminars in thrombosis and hemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 18:12:37